Phenyltoloxamine
| |
| Phenyltoloxamine
| |
| Systematic (IUPAC) name | |
| N,N-dimethyl-2-(α-phenyl-O-tolyloxy)ethylamine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C17H21NO |
| Mol. mass | 255.359 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | oral |
|
WikiDoc Resources for Phenyltoloxamine | |
|
Articles | |
|---|---|
|
Most recent articles on Phenyltoloxamine Most cited articles on Phenyltoloxamine | |
|
Media | |
|
Powerpoint slides on Phenyltoloxamine | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Phenyltoloxamine at Clinical Trials.gov Trial results on Phenyltoloxamine Clinical Trials on Phenyltoloxamine at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Phenyltoloxamine NICE Guidance on Phenyltoloxamine
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Phenyltoloxamine Discussion groups on Phenyltoloxamine Patient Handouts on Phenyltoloxamine Directions to Hospitals Treating Phenyltoloxamine Risk calculators and risk factors for Phenyltoloxamine
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Phenyltoloxamine | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Phenyltoloxamine is an antihistamine with sedative and analgesic effects. It is a member of the ethanolamine class of antihistaminergic agents and a potent anticholinergic.
Common use
Phenyltoloxamine is widely used in preparations as an enhancing agent for some analgesics and antitussives (acetaminophen, codeine, hydrocodone). It is widely used in certain parts of the world as cough suppressant usually with codeine.
It also used to discourage abuse in certain opiate analgesics due its unpleasant side effects at high doses.
Adverse effects
Common adverse effects are those associated with most anticholinergics, effects are more pronounced in children and the elderly.
- See also: anticholinergic
Availability
Phenyltoloxamine is available in most countries, though is rare in several western countries it remains widely used around the world, particularly in the developing world.
It is not a controlled substance; however some preparations contain opiates such as codeine or hydrocodone and are controlled, when used in preparations with acetaminophen is generally over the counter.
Phenyltoloxamine is sold under wide variety of preparations, brand names and dosages around the world:
- Ed-Flex, Dologesic, Flextra-650, Novagesic, Phenylgesic - North America
- Codipront - Europe/South America
WikiDoc Research Resources for Phenyltoloxamine | |
|---|---|
| Articles on Phenyltoloxamine | Most recent articles on Phenyltoloxamine • Most cited articles on Phenyltoloxamine • Review articles on Phenyltoloxamine • Articles on Phenyltoloxamine in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Phenyltoloxamine | Powerpoint slides on Phenyltoloxamine • Images of Phenyltoloxamine • Photos of Phenyltoloxamine • Podcasts & MP3s on Phenyltoloxamine • Videos on Phenyltoloxamine |
| Evidence Based Medicine Regarding Phenyltoloxamine | AND (Cochrane Database Syst Rev[http://worldselectshop.com/?id=9361 Cochrane Collaboration on Phenyltoloxamine • Bandolier on Phenyltoloxamine • TRIP on Phenyltoloxamine |
| Cost Effectiveness of Phenyltoloxamine | AND (Cost effectiveness) |
| group5 = Clinical Trials Involving Phenyltoloxamine | list5 = Ongoing Trials on Phenyltoloxamine at Clinical Trials.gov • Trial results on Phenyltoloxamine • Clinical Trials on Phenyltoloxamine at Google
| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Phenyltoloxamine
| list6 = US National Guidelines Clearinghouse on Phenyltoloxamine • NICE Guidance on Phenyltoloxamine • NHS PRODIGY Guidance • FDA on Phenyltoloxamine • CDC on Phenyltoloxamine
| group7 = Textbook Information on Phenyltoloxamine
| list7 = Books and Textbook Information on Phenyltoloxamine
| group8 = Pharmacology Resources on Phenyltoloxamine
| list8 =
AND (Dose)}} Dosing of Phenyltoloxamine • AND (drug interactions)}} Drug interactions with Phenyltoloxamine • AND (side effects)}} Side effects of Phenyltoloxamine • AND (Allergy)}} Allergic reactions to Phenyltoloxamine • AND (overdose)}} Overdose information on Phenyltoloxamine • AND (carcinogenicity)}} Carcinogenicity information on Phenyltoloxamine • AND (pregnancy)}} Phenyltoloxamine in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Phenyltoloxamine •
| group9 = Genetics, Pharmacogenomics, and Proteinomics of Phenyltoloxamine
| list9 =
AND (pharmacogenomics)}} Genetics of Phenyltoloxamine • AND (pharmacogenomics)}} Pharmacogenomics of Phenyltoloxamine • AND (proteomics)}} Proteomics of Phenyltoloxamine
| group10 = Newstories on Phenyltoloxamine
| list10 = Phenyltoloxamine in the news • Be alerted to news on Phenyltoloxamine • News trends on Phenyltoloxamine</small>
| group11 = Commentary on Phenyltoloxamine
| list11 =
Blogs on Phenyltoloxamine
| group12 = Patient Resources on Phenyltoloxamine | list12 = Patient resources on Phenyltoloxamine • Discussion groups on Phenyltoloxamine • Patient Handouts on Phenyltoloxamine • Directions to Hospitals Treating Phenyltoloxamine • Risk calculators and risk factors for Phenyltoloxamine
| group13 = Healthcare Provider Resources on Phenyltoloxamine
| list13 =
Symptoms of Phenyltoloxamine • Causes & Risk Factors for Phenyltoloxamine • Diagnostic studies for Phenyltoloxamine • Treatment of Phenyltoloxamine
| group14 = Continuing Medical Education (CME) Programs on Phenyltoloxamine | list14 = CME Programs on Phenyltoloxamine
| group15 = International Resources on Phenyltoloxamine | list15 = Phenyltoloxamine en Espanol • Phenyltoloxamine en Francais
| group16 = Business Resources on Phenyltoloxamine | list16 = Phenyltoloxamine in the Marketplace • Patents on Phenyltoloxamine
| group17 = Informatics Resources on Phenyltoloxamine | list17 = List of terms related to Phenyltoloxamine
}}
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
